A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients

Detalles del proyecto

EstadoFinalizado
Fecha de inicio/Fecha fin7/1/08 → 7/31/14

Financiación

  • Novartis (domestic): 170.847,00 US$